| Abstract |
Patients infected with COVID-19 can develop coinfections or acute respiratory disorder that result in ventilation. Dexmedetomidine is a common medication used to sedate ventilated patients in the intensive care unit and for nonintubated patients prior to a surgical procedure. As a highly selective alpha-2 agonist, dexmedetomidine provides sedation while reducing the need for anxiolytics or opioids. However, previous case reports suggest dexmedetomidine can induce fever in a variety of conditions. The purpose of this case report is to describe a patient who acquired a fever of 42.6°C in the setting of COVID-19 after administration of dexmedetomidine. |
| Authors |
Megan Meier  , Becky S Linn 
|
| Journal Info |
SAGE Publishing | Journal of Investigative Medicine High Impact Case Reports , vol: 12
|
| Publication Date |
1/1/2024 |
| ISSN |
2324-7096 |
Type |
article |
| Open Access |
gold
|
| DOI |
https://doi.org/10.1177/23247096241260959 |
| Keywords |
Dexmedetomidine (Score: 0.563132)
|
